PROM1 and gastrointestinal stromal tumor: Interestingly, elevated expression of the CD133 in the tumor are associated with increasing poor clinical outcomes in a varieties of epithelial cancers [7] as well as in GIST [8] The range of CD133 expressions among different types of cancers varies greatly in a range 1–25% of the primary tumors [9].